NCT06024824 - Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 30, 2024

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2031

Conditions

Pancreatic Adenocarcinoma

Interventions

RADIATION

Dose-Painted Intensity Modulated Radiotherapy

"Fifteen fractions of external beam radiation therapy (EBRT) delivered via IMRT/ VMAT.~Cohort 1 (n = 3-6) Single PTV 40.05 Gy/15#, homogenous dose. Cohort 2 (n = 3-6) High Risk PTV 45 Gy/15# SIB to PTV tumour, Elective PTV 40.05 Gy/15# to nodal regions.~Cohort 3 (n = 3-6) High risk PTV 48 Gy/15# SIB to PTV tumour, Elective PTV 40.05 Gy/15# to nodal regions."

Trial Locations (2)

Unknown

RECRUITING

St Luke's Radiation Oncology Network (SLRON), Dublin

RECRUITING

St Vincent's University Hospital, Dublin

All Listed Sponsors

lead

Cancer Trials Ireland

NETWORK